CD4+T CELL EXPANSIONS IN HIV

HIV 中的 CD4 T 细胞扩增

基本信息

  • 批准号:
    2802466
  • 负责人:
  • 金额:
    $ 22.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-01 至 2000-08-31
  • 项目状态:
    已结题

项目摘要

This application proposes to use PBMC specimens collected from two ACTG protocols to retrospectively study clonal expansions in the CD4 lymphocyte repertoire that occur in HIV infection and their response(s) to HAART. The PI has recently identified large clonal/oligoclonal expansions in CD4 cells in a limited number of patients with HIV. Previous work by the PI has shown that clonal expansions of CD4 cells in the periphery are not found in a large sampling of 147 healthy children and adults, from a broad range of ages, or in autoimmune disease states, such as rheumatoid arthritis. Therefore, such clonal CD4 cell expansions may be unique to HIV infection. It is hypothesized that the expanded CD4 cell clones arise from proliferation to specific HIV antigens, but they have been rendered functionally deficient by the disease process. The goal of this proposal is to determine the clonal or oligoclonal nature of CD4 cell subsets that express particular TCR V-beta determinants in HIV patients, prior to therapy and following up to 80 weeks of HAART. Subsets representing both expanded and non- expanded V-beta phenotypes will be analyzed to: 1) compare their proliferative capacity in vitro, 2) determine changes in TCR diversity following HAART, and 3) derive TCR sequences to be expressed in a transgenic hybridoma cell model to screen for specific reactivity to HIV antigen epitopes. In addition, experiments will be done to determine whether expanded subsets of CD4 cells harbor increased HIV DNA load in comparison to non-expanded subsets, and whether any differential levels in viral DNA persist following extended HAART.
本应用程序建议使用从两个ACTG收集的PBMC标本

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian L Kotzin其他文献

The potential role of superantigens in Kawasaki disease(KD)
  • DOI:
    10.1016/s1058-9813(06)80081-0
  • 发表时间:
    1992-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jun Abe;Joseph Forrester;Takako Nakahara;Brian L Kotzin;Donald YM Leung
  • 通讯作者:
    Donald YM Leung

Brian L Kotzin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian L Kotzin', 18)}}的其他基金

T CELL RECEPTOR REPERTOIRE AND SUPERANTIGENS IN RHEUMATOID ARTHRITIS
类风湿关节炎中的 T 细胞受体库和超抗原
  • 批准号:
    6566361
  • 财政年份:
    2000
  • 资助金额:
    $ 22.35万
  • 项目类别:
T CELL RECEPTOR REPERTOIRE AND SUPERANTIGENS IN RHEUMATOID ARTHRITIS
类风湿关节炎中的 T 细胞受体库和超抗原
  • 批准号:
    6504509
  • 财政年份:
    2000
  • 资助金额:
    $ 22.35万
  • 项目类别:
DENVER AUTOIMMUNITY CENTER OF EXCELLENCE
丹佛自身免疫卓越中心
  • 批准号:
    6170707
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
AUTOIMMUNITY CENTER OF EXCELLENCE
自身免疫卓越中心
  • 批准号:
    6021948
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
DENVER AUTOIMMUNITY CENTER OF EXCELLENCE
丹佛自身免疫卓越中心
  • 批准号:
    6534210
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
Denver Autoimmunity Center of Excellence
丹佛自身免疫卓越中心
  • 批准号:
    6685600
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
DENVER AUTOIMMUNITY CENTER OF EXCELLENCE
丹佛自身免疫卓越中心
  • 批准号:
    6374322
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
T CELL RECEPTOR REPERTOIRE AND SUPERANTIGENS IN RHEUMATOID ARTHRITIS
类风湿关节炎中的 T 细胞受体库和超抗原
  • 批准号:
    6304253
  • 财政年份:
    1999
  • 资助金额:
    $ 22.35万
  • 项目类别:
CD4+T CELL EXPANSIONS IN HIV
HIV 中的 CD4 T 细胞扩增
  • 批准号:
    2887951
  • 财政年份:
    1998
  • 资助金额:
    $ 22.35万
  • 项目类别:
PATHOGENIC T CELLS IN CHRONIC BERYLLIUM DISEASE
慢性铍病中的致病性 T 细胞
  • 批准号:
    6390308
  • 财政年份:
    1998
  • 资助金额:
    $ 22.35万
  • 项目类别:

相似海外基金

Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 22.35万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 22.35万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 22.35万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 22.35万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 22.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了